Bank of Baroda reported a 17.42% year-on-year advance growth to Rs 14.2 lakh crore and a 13.81% deposit growth to Rs 16.3 lakh crore at the end of the June quarter, despite a sequential contraction in both assets and liabilities from March 2026 levels.

Bank of Baroda has settled a legal dispute with NMC Health entities for USD 600 million, resolving claims under UAE and UK regulations, while also reporting a 17% credit growth and a 14% increase in total deposits in Q1 FY27.

Bank of Baroda has settled litigation with NMC Health for Rs 5,700 crore, covering proceedings in the Abu Dhabi Global Market Court and the High Court of Justice of England and Wales, with the settlement amount being paid by its Abu Dhabi branch. The bank stated that its liability is limited to the agreed settlement amount and aims to conclude disputes to avoid prolonged litigation and associated costs.

Bank of Baroda has raised external commercial borrowings since the relaxation of regulations by the Reserve Bank of India, indicating a proactive approach to accessing foreign debt.

Bank of Baroda has partnered with Mizuho Bank to enhance their capabilities in mergers and acquisitions financing, focusing on joint origination, structuring, and syndication of acquisition financing, as well as MA advisory and risk distribution.

Bank of Baroda announced a dividend of Rs 2,811 crore for the fiscal year 2025-26, which is 425% of the face value of Rs 2 per share, reflecting its robust financial health.

Bank of Baroda is expected to experience outflows of 10 million due to changes in its index weight.

Bank of Baroda has also decided to pause its dollar bond issuance plans due to investor demands for higher spreads over US Treasuries, reflecting a cautious approach in the current market conditions.